SHARA RAQS

Led product development for an FDA-cleared at-home hormone testing platform and AI health insights engine, serving over 50,000 users.

• Spearheaded telehealth expansion through clinical partnerships with Midi Health, scaling midlife and perimenopause management services across platform.
• Directed wearable health integrations with Google Health Connect and Oura, enabling advanced multi-parameter analysis for comprehensive women's health monitoring.
• Developed FDA-cleared AI-powered hormone pattern recognition algorithms, achieving 99% accuracy across FSH, LH, estrogen, and progesterone detection.
• Architected a complete end-to-end fertility testing system, integrating telehealth for prescription access and creating care pathway alternatives to traditional IVF treatment.
• Collaborated with cross-functional teams of engineering, design, clinical, data, and regulatory to successfully launch 3 major product lines in a regulated environment.
• Scaled the consumer health platform from startup to widespread retail distribution across 6,500+ Target and Walgreens locations, alongside direct-to-consumer channels.

Founded and led a pre-seed neurotechnology startup, pioneering first-to-market digital therapeutics for hormone-brain health before the FemTech investment surge.

• Initiated and bootstrapped a neurotechnology startup based on proprietary research that predated mainstream neuroscience discoveries by 3 years.
• Managed the full product commercialization lifecycle, from research validation and MVP development to user testing and market validation with early adopters.
• Engineered patent-pending algorithms to translate complex neuroscience research into personalized digital health interventions for hormonal and neurocognitive fluctuations.
• Achieved 97% improvement in mind-body awareness and mental health outcomes for pilot participants.
• Strategically transitioned core expertise and technology to an established hormone health diagnostics platform, anticipating market readiness for women's digital health solutions.

Led pioneering digital biomarker research for women's health that resulted in a 7-cycle participatory research study in collaboration with the Kriegsfeld Neurobiology Lab, Oura and the Quantified Self Q-Cycle research initiative.

• Led breakthrough digital biomarker research, including a validated 7-cycle study with Berkeley Neurobiology Lab, decoding brain state and ovarian hormone correlations.
• Pioneered research identifying neurological transition states across hormonal phases, preceding mainstream scientific acceptance by several years and now widely recognized.
• Resulted in a utility patent application and established foundational datasets for next-generation cycle-aware health platforms.

Managed enterprise health platform development for Duke University Eye Center, delivering clinical workflow solutions and web applications for academic medical environments.